Reform of pharma legislation: the debate on regulatory data protection
by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
The EU Commission proposal of the new pharmaceutical legislation
By Giuliana Miglierini After a five-months delay, the European Commission has announced on 26 April 2023 its proposal…
The main contributions to the consultation on the revision of the pharmaceutical legislation
by Giuliana Miglierini The European Commission has published the summary of the outcomes of the public consultation on…
A new role for EMA and a pilot project for the repurposing of medicines
by Giuliana Miglierini A draft agreement was reached at the end of October between the Council of the…
Consultation on the reform of the European pharmaceutical legislation
by Giuliana Miglierini A new step in the review of the overall framework governing the pharmaceutical sector has…
The opportunity for repurposing of oncology medicines
by Giuliana Miglierini Rare cancers, which account for approx. 22% of new cases in Europe, represent an area…